))
A new way to finance drug development, for rare disease and beyond | Talking Precision Medicine #28
Manage episode 348469439 series 3103485
Content provided by Genialis. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Genialis or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, our host and Genialis CEO Rafael Rosengarten spotlights Vibe Bio. Vibe Bio is a new biotech aiming to disrupt how we finance drug development through stakeholder communities and cryptocurrency, starting in the rare disease arena. Our guest is Alok Tayi, co-founder and CEO of Vibe. Alok is a successful serial entrepreneur and a rare disease community member.
Visit TPM E28 for highlights and links from this episode.
37 episodes
Share
